Document is current
Any future updates will be listed below
-
Authors
Hu, Zhe-Yu
Yan, Min
Xiong, Huihua
Ran, Li
Zhong, Jincai
Luo, Ting
Sun, Tao
Xie, Ning
Liu, Liping
Yang, Xiaohong
Xiao, Huawu
Li, Jing
Liu, Binliang
Ouyang, Quchang
-
Funding
Funding for this research was provided by:
Climb Plan of Hunan Cancer Hospital (No. ZX2021005)
Chinese Anti-Cancer Association HER2 target Chinese Research Fund (No. CORP-239-S5)
Changsha Science and Technology Project (kq2004137)
Hunan Provincial Natural Science Foundation of China (2023JJ60464)
- License Information
-
More Information
Article History
Received: 8 December 2022
Accepted: 14 June 2023
First Online: 26 June 2023
Declarations
:
: According to the ethical guidelines of the Helsinki Declaration, the experimental protocol was established and approved by the Hunan Cancer Hospital (HR-BLTN-008). The study was registered with ClinicalTrials.gov (NCT04407988). Written informed consent was obtained from all individuals or guardian participants.
: Not applicable.
: The authors declare that they have no financial/non-financial competing interests.
